Monroe Carell Jr. Children’s Hospital at Vanderbilt has been named an accredited center of care by the Children’s Cardiomyopathy Foundation, a national nonprofit committed to improving the health outcomes and quality of life for children with cardiomyopathy.
The Pediatric Cardiomyopathy Program at Children’s Hospital is one of only a few such programs in Tennessee.
Cardiomyopathy is a chronic heart disease that affects how the heart pumps blood through the body.
Children’s Hospital received this recognition for providing consistent high-quality cardiac care and
specialized disease management to children with cardiomyopathy.
The program also was recently named a center of excellence for hypertrophic cardiomyopathy by the Hypertrophic Cardiomyopathy Association (HCMA), a nonprofit organization that provides support, advocacy and education to patients and health care professionals. The Pediatric Hypertrophic Cardiomyopathy Program at Vanderbilt is one of a few pediatric programs in the country to receive HCMA center of excellence designation.
Pediatric cardiomyopathy is a complex and variable disease with only a quarter of those diagnosed having a known cause. The disease requires a team approach to providing comprehensive care.